ABSTRACT
As a powerful attempt by government to promote the construction of the multi-level healthcare security system and social and commercial integration in China, " City-customized Medical Insurance" still has many problems to be solved at the beginning of its development, such as unclear boundary between government and enterprises, limited coverage and strength of security. On the basis of clarifying the current situation of " City-customized Medical Insurance", and combing the management experience of social and commercial integration in Medicare Part C plan of the United States, the authors put forward that China should make full use of the advantages of the combination of promising government and efficient market, guide differentiated product design, and establish market access and evaluation mechanism, so as to promote the effective connection between China′s commercial health insurance and basic healthcare insurance, and further reduce the people′s medical burden.
ABSTRACT
OBJECTIVE： To provide refe rence for improving the performance of drug supply chain and sustainable development of the pharmaceutical industry in China . METHODS ：By collecting literatures and combining with the characteristics of drug supply chain ，the questionnaire was designed with Likert 5 scale. After the questionnaire was tested and modified by 10 experts，a preliminary index system framework was formed. The formal questionnaire was prepared by the questionnaire test method；37 experts were consulted by Delphi method ，the index weight was determined by AHP method ，and the index reliability was tested by statistical analysis method ；finally，a pharmaceutical enterprise was taken as an example to measure the index system. RESULTS ：The positive coefficient of the first round of expert consultation was 100％，and that of the second round was 94.59％；average degree of authority of experts was 0.832 6；expert coordination coefficient of the first round was 0.218 2，and that of the second round was 0.396 5. The green supply chain performance indicator system of the pharmaceutical industry included 6 first-level indicators and 26 second-level indicators ，such as drug greenness ，green marketing ，operation process ，drug quality ， drug safety and drug economy. The consistency ratio of the first-level indexes and all second-level indexes were all less than 0.1， the overall Cronbach ’s α coefficient of the index system was 0.892 1. The measured results of a pharmaceutical enterprise showed that the highest score of the pharmaceutical enterprise was the “drug quality ”index，with an absolute score of 3.962 7；the lowest score was the “drug greenness ”index，with an absolute score of 2.297 9. The green supply chain performance evaluation score was 3.167 8，which was at a medium level. CONCLUSIONS ：The established index system has good reliability and validity ，and is expected to provide reference for the performance evaluation of green supply chain in China ’s pharmaceutical industry.
ABSTRACT
Objective To build an indicator system of pharmaceutical supply chain performance using the theory of balanced scored card(BSC). Methods A preliminary indicator system was built by way of literature analysis during February-October of 2017, with a formal questionnaire prepared by means of the questionnaire test method. Two rounds of expert consultation were carried out in Delphi method, and the statistical analysis method was used to determine the index weight and the reliability, with the system applied. Results Such a system consisted of seven level-1 indicators and 22 level-2 indicators. The content efficiency index of the system was 0.833, and the total Cronbach a index was 0.892, indicating satisfactory efficiency and reliability. Conclusions This system established in the study proves scientific and feasible, and can provide reference for hospitals to improve their performance of the pharmaceutical supply chain.